Getz Pharma Enters Into A Joint Venture With Tabba Heart
Getz Pharma Enters Into A Joint Venture With Tabba Heart Getz Pharma and Tabba Heart Institute, to address the issue of the rising health burden of ASCVD in Pakistan, are entering into a Joint Venture Agreement for the largest, first-of-its-kind, longitudinal cohort study on Atherosclerotic Risk Assessment in Pakistani Population. This study aims to recruit healthy volunteers aged 30 years or older from selected urban and rural areas of Pakistan who are asymptomatic and have no cardiovascular disease. This would allow for assessing the participants’ risk factor profiles and follow them up f...